Chia Tai Enterprises International Limited
CAIHF · OTC
Company research
Chia Tai Enterprises International Limited (CAIHF), incorporated in 1987 and headquartered in Central, Hong Kong, is an investment holding company primarily engaged in the manufacture and sale of animal health products and chlortetracycline (CTC), operating across Mainland China, the Asia Pacific, the Americas, Europe, and other international markets. The company operates through two segments: the Biochemical segment, which focuses on the production and commercialization of CTC premix and CTC hydrochloride used as feed additives for livestock under the "Shihao" and "Citifac" brand names; and the Industrial segment, which is engaged in the trading of Caterpillar machinery equipment as well as the manufacture and sale of automotive parts and carburetors. With approximately 900 full-time employees and a market capitalization of approximately USD 217 million, the company derives the majority of its revenue from its Biochemical operations, with Mainland China being its key revenue-generating market. CTEI operates as a subsidiary of Charoen Pokphand Foods Public Company Limited and is listed on the OTC markets under the ticker symbol CAIHF.
Research reports
This report applies Simply Wall St’s fundamental “Snowflake” model to Chia Tai Enterprises (HK:3839/CAIHF), highlighting that the shares trade well below its internal fair-value estimate, with strong recent earnings growth, solid margins, and healthy financial health metrics. It frames the stock as a potential long-term compounder with improving returns on capital and resilient balance sheet quality, while noting high share-price volatility but explicitly stating that their risk checks currently detect no major red flags.
Stock Expert AI · June 15, 2026CAIHF Stock Analysis: AI Grade BThis AI-driven report sets out a detailed investment thesis for CAIHF, emphasizing the company’s dual Biochemical (chlortetracycline feed additives) and Industrial (Caterpillar machinery and automotive parts) segments, alongside profitability metrics such as a market cap around 0.22 bn, P/E near 9, profit margin about 6.4%, and gross margin around 15.8%. It balances multiple growth drivers (global protein demand, infrastructure spending, automotive aftermarket) against key risks like OTC listing with low disclosure, high beta-driven volatility, regulatory uncertainty around feed additives, and cyclicality in machinery and auto parts, resulting in a moderate “hold” stance with an AI MoonshotScore of 53/100.